---
title: "CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294735797.md"
description: "In Zug, Switzerland and Boston, financial results for the second quarter ending on June 30, 2026 were reported by CRISPR Therapeutics (Nasdaq: CRSP)."
datetime: "2026-08-03T20:18:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294735797.md)
  - [en](https://longbridge.com/en/news/294735797.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294735797.md)
generator: "portal-rs"
---

# CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

In Zug, Switzerland and Boston, financial results for the second quarter ending on June 30, 2026 were reported by CRISPR Therapeutics (Nasdaq: CRSP).

### Related Stocks

- [CRSP.US](https://longbridge.com/en/quote/CRSP.US.md)

## Related News & Research

- [Raiffeisen Bank International AG Buys Shares of 20,000 CRISPR Therapeutics AG $CRSP](https://longbridge.com/en/news/298128987.md)
- [CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data](https://longbridge.com/en/news/297413766.md)
- [Shah Wealth Advisors LLC Buys New Position in CRISPR Therapeutics AG $CRSP](https://longbridge.com/en/news/298108618.md)
- [CRISPR Therapeutics (NASDAQ:CRSP) Earns Market Outperform Rating from Citizens Jmp](https://longbridge.com/en/news/296922645.md)
- [Brave Asset Management Inc. Cuts Stake in CRISPR Therapeutics AG $CRSP](https://longbridge.com/en/news/295199690.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**